申请人:Merrell Pharmaceuticals Inc.
公开号:US05670521A1
公开(公告)日:1997-09-23
Certain triphenylpiperidines reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
某些三苯基哌啶可以逆转多药耐药肿瘤。这些化合物显然通过抑制在晚期肿瘤发展中被激活并固有于某些来源的肿瘤中的p-糖蛋白泵来发挥作用。